首页 > 最新文献

Digestive Diseases最新文献

英文 中文
Potential Risk Factors of Disorders of Gut-Brain Interaction in Undergraduates and Postgraduates: Partially Mediated by Life Stress and Lifestyle. 大学生和研究生肠脑互动失调的潜在风险因素:部分受生活压力和生活方式的影响。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-06-05 DOI: 10.1159/000539552
Likun Zhong, Yunxiao Liang, Huikuan Chu, Xiujing Zhang, Jingzhi Zhang, Xiaohua Hou, Zhiyue Xu

Introduction: This study aimed to investigate the prevalence of disorders of gut-brain interaction (DGBI) and life stress in college students, and explore risk factors of DGBI in college students and the role of life stress.

Methods: A total of 2,578 college students filled up validated questionnaires assessing GI symptoms, lifestyle, and life stress. Participants were diagnosed as DGBI based on the Rome III criteria. Multivariate ordinal logistic regression analysis and mediation effect model were employed to explore potential risk factors of DGBI and the mediating role of life stress and lifestyle in DGBI.

Results: A total of 437 of 2,578 (17.0%) college students were diagnosed with DGBI. College students with DGBI had higher levels of life stress, including eight specific categories. Females (1.709 [1.437, 2.033]), staying up late (1.519 [1.300, 1.776]), and life stress (1.008 [1.006, 1.010]) were risk factors for DGBI, while postgraduates (0.751 [0.578, 0.976]) and regular diet (0.751 [0.685, 0.947]) were protective factors. Males and poor family economic were associated with a higher risk of DGBI after controlling stress, while an association between grade and DGBI was mediated by stress, regular diet, and sleep habits.

Conclusion: DGBI was common among college students. Life stress and lifestyle were associated with DGBI and mediated partial association between grade and DGBI in college students. More attention should be paid to undergraduates.

研究目的本研究旨在调查大学生肠脑互动障碍(DGBI)的患病率和生活压力,并探讨大学生肠脑互动障碍的风险因素和生活压力的作用。方法:2578名大学生填写了有效问卷,评估消化道症状、生活方式和生活压力。根据罗马III标准,参与者被诊断为DGBI。采用多变量序数逻辑回归分析和中介效应模型探讨DGBI的潜在风险因素以及生活压力和生活方式在DGBI中的中介作用:结果:2578名大学生中有437名(17.0%)被诊断为DGBI。患有 DGBI 的大学生的生活压力水平较高,包括八个具体类别。女性(1.709 [1.437, 2.033])、熬夜(1.519 [1.300, 1.776])和生活压力(1.008 [1.006, 1.010])是 DGBI 的危险因素,而研究生(0.751 [0.578, 0.976])和规律饮食(0.751 [0.685, 0.947])则是保护因素。在控制压力后,男性和贫困家庭经济与较高的 DGBI 风险相关,而年级与 DGBI 之间的关系则由压力、规律饮食和睡眠习惯介导:结论:DGBI在大学生中很常见。结论:DGBI在大学生中很常见,生活压力和生活方式与DGBI有关,并介导了成绩与DGBI之间的部分关联。对大学生应给予更多关注。
{"title":"Potential Risk Factors of Disorders of Gut-Brain Interaction in Undergraduates and Postgraduates: Partially Mediated by Life Stress and Lifestyle.","authors":"Likun Zhong, Yunxiao Liang, Huikuan Chu, Xiujing Zhang, Jingzhi Zhang, Xiaohua Hou, Zhiyue Xu","doi":"10.1159/000539552","DOIUrl":"10.1159/000539552","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to investigate the prevalence of disorders of gut-brain interaction (DGBI) and life stress in college students, and explore risk factors of DGBI in college students and the role of life stress.</p><p><strong>Methods: </strong>A total of 2,578 college students filled up validated questionnaires assessing GI symptoms, lifestyle, and life stress. Participants were diagnosed as DGBI based on the Rome III criteria. Multivariate ordinal logistic regression analysis and mediation effect model were employed to explore potential risk factors of DGBI and the mediating role of life stress and lifestyle in DGBI.</p><p><strong>Results: </strong>A total of 437 of 2,578 (17.0%) college students were diagnosed with DGBI. College students with DGBI had higher levels of life stress, including eight specific categories. Females (1.709 [1.437, 2.033]), staying up late (1.519 [1.300, 1.776]), and life stress (1.008 [1.006, 1.010]) were risk factors for DGBI, while postgraduates (0.751 [0.578, 0.976]) and regular diet (0.751 [0.685, 0.947]) were protective factors. Males and poor family economic were associated with a higher risk of DGBI after controlling stress, while an association between grade and DGBI was mediated by stress, regular diet, and sleep habits.</p><p><strong>Conclusion: </strong>DGBI was common among college students. Life stress and lifestyle were associated with DGBI and mediated partial association between grade and DGBI in college students. More attention should be paid to undergraduates.</p>","PeriodicalId":11294,"journal":{"name":"Digestive Diseases","volume":" ","pages":"391-398"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141261223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction Statement. 撤回声明。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-06-27 DOI: 10.1159/000539915
{"title":"Retraction Statement.","authors":"","doi":"10.1159/000539915","DOIUrl":"10.1159/000539915","url":null,"abstract":"","PeriodicalId":11294,"journal":{"name":"Digestive Diseases","volume":"42 4","pages":"389"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141476177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Cirrhotic Patients by the EncephalApp Fails to Predict Low-Grade Hepatic Encephalopathy. 用 EncephalApp 评估肝硬化患者无法预测低度肝性脑病。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-06-12 DOI: 10.1159/000538924
Rebecca Maria Neye, Gerald Kircheis, Daria Stratmann, Norbert Hilger, Stefan Lüth

Introduction: An early detection of low-grade hepatic encephalopathy (HE) is of high importance. The aim of the study was to compare a neuropsychological with a psychophysical test on the basis of the psychometric hepatic encephalopathy score (PHES) regarding effectiveness in diagnosing minimal HE (MHE).

Methods: In our prospective controlled observational study, we examined a total of 103 patients with liver cirrhosis for HE. The PHES, CFF, and EncephalApp were performed in all patients. Graduation was based on the result of the PHES. Patients without evidence for HE 1&2 according to the mental state (West-Haven criteria) with a PHES <-4 value points and no clinical symptoms were defined as having MHE. Patients were considered as HE0 when in the PHES none of the psychometric subtest results was abnormal or with a PHES ≥-4 value points. Patients with clinical symptoms were considered HE 1&2 patients. Different cut-off values were determined, and their specificity and sensitivity were calculated.

Results: Ninety-six of the involved patients had liver cirrhosis and 25 acted as a healthy control group. The ROC analysis for the classification resulted in an AUC of 0.806, with the highest Youden index for the cut-off time >224 s, for which the sensitivity was 82% and the specificity 75%. Cases of withdrawals were seen in 10.74% of all tested patients.

Conclusion: The EncephalApp distinguishes well between HE0 and MHE but has its limitations in grading higher forms of HE. Diagnosis using only the EncephalApp is not sufficient.

简介早期发现低度肝性脑病(HE)非常重要。本研究的目的是在心理测量肝性脑病评分(PHES)的基础上,比较神经心理学测试和心理物理学测试在诊断轻度肝性脑病(MHE)方面的有效性:在前瞻性对照观察研究中,我们共对 103 名肝硬化患者进行了肝性脑病检查。所有患者均接受了 PHES、CFF 和 EncephalApp 检查。根据 PHES 的结果进行分级。根据精神状态(West-Haven 标准)无证据表明患有 HE 1 和 HE 2,且 PHES < -4 值点且无临床症状的患者被定义为 MHE。在心理测验中,如果没有一项心理测验的结果出现异常,或心理测验的 PHES  -4 值点,则患者被视为 HE 0。有临床症状的患者被视为 HE 1 和 HE 2 患者。确定了不同的临界值,并计算了其特异性和敏感性:结果:96 名患者患有肝硬化,25 名患者为健康对照组。分类的 ROC 分析得出的 AUC 为 0.806,截止时间为 224 秒时的尤登指数最高,灵敏度为 82%,特异度为 75%。在所有接受测试的患者中,有 10.74% 的患者出现了停药情况。讨论/结论EncephalApp 能很好地区分 HE0 和 MHE,但在分级更高级别的 HE 时有其局限性。仅使用 EncephalApp 进行诊断是不够的。
{"title":"Assessment of Cirrhotic Patients by the EncephalApp Fails to Predict Low-Grade Hepatic Encephalopathy.","authors":"Rebecca Maria Neye, Gerald Kircheis, Daria Stratmann, Norbert Hilger, Stefan Lüth","doi":"10.1159/000538924","DOIUrl":"10.1159/000538924","url":null,"abstract":"<p><strong>Introduction: </strong>An early detection of low-grade hepatic encephalopathy (HE) is of high importance. The aim of the study was to compare a neuropsychological with a psychophysical test on the basis of the psychometric hepatic encephalopathy score (PHES) regarding effectiveness in diagnosing minimal HE (MHE).</p><p><strong>Methods: </strong>In our prospective controlled observational study, we examined a total of 103 patients with liver cirrhosis for HE. The PHES, CFF, and EncephalApp were performed in all patients. Graduation was based on the result of the PHES. Patients without evidence for HE 1&amp;2 according to the mental state (West-Haven criteria) with a PHES <-4 value points and no clinical symptoms were defined as having MHE. Patients were considered as HE0 when in the PHES none of the psychometric subtest results was abnormal or with a PHES ≥-4 value points. Patients with clinical symptoms were considered HE 1&amp;2 patients. Different cut-off values were determined, and their specificity and sensitivity were calculated.</p><p><strong>Results: </strong>Ninety-six of the involved patients had liver cirrhosis and 25 acted as a healthy control group. The ROC analysis for the classification resulted in an AUC of 0.806, with the highest Youden index for the cut-off time >224 s, for which the sensitivity was 82% and the specificity 75%. Cases of withdrawals were seen in 10.74% of all tested patients.</p><p><strong>Conclusion: </strong>The EncephalApp distinguishes well between HE0 and MHE but has its limitations in grading higher forms of HE. Diagnosis using only the EncephalApp is not sufficient.</p>","PeriodicalId":11294,"journal":{"name":"Digestive Diseases","volume":" ","pages":"567-575"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141310332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathological Features of Early Gastric Cancer Complicated by Autoimmune Gastritis. 自身免疫性胃炎并发早期胃癌的临床病理特征
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-06-04 DOI: 10.1159/000539639
Kosuke Nomura, Daisuke Kikuchi, Yusuke Kawai, Yorinari Ochiai, Takayuki Okamura, Yugo Suzuki, Junnosuke Hayasaka, Yutaka Mitsunaga, Hiroyuki Odagiri, Satoshi Yamashita, Akira Matsui, Shu Hoteya

Introduction: In the post-Helicobacter pylori era, autoimmune gastritis (AIG) is attracting increasing attention as an origin of gastric cancer. Here, we performed clinicopathological examination of gastric cancer complicating AIG treated in our hospital.

Methods: Eighty-six early gastric cancer lesions complicating AIG in 50 patients were treated by endoscopic submucosal dissection (ESD) at our hospital in 2008-2022. Their clinicopathological characteristics were compared with those of a control group comprising 2,978 early gastric cancer lesions (excluding lesions in the remnant stomach after surgery) in 2,278 patients treated by ESD during the same period.

Results: Mean age was significantly higher in the AIG group than in the control group (74.7 years vs. 70.9 years; p < 0.01). In the respective groups, the occurrence rate of synchronous/metachronous lesions was 38.0% and 20.4% (p < 0.01), the ratio of longitudinal cancer locations (upper/middle/lower third [U/M/L]) was 27/32/27 and 518/993/1,467 (p < 0.01), the ratio of circumferential cancer locations (lesser curvature/greater curvature/anterior wall/posterior wall) was 25/31/12/18 and 1,259/587/475/657 (p < 0.01), the ratio of major macroscopic types (I/IIa/IIb/IIc) was 13/38/5/30 and 65/881/220/1,812 (p < 0.01). The rates of multiple gastric cancer and cancers in the U region, at the greater curvature, and of protruding types were significantly higher in the AIG group.

Conclusion: The occurrence rate of multiple gastric cancer was significantly higher in gastric cancer complicating AIG (approximately 40%), and compared with the control group, the proportions of cancers at the U region, at the greater curvature, and of protruding types were significantly higher.

背景:在后幽门螺杆菌时代,自身免疫性胃炎(AIG)作为胃癌的起源之一正引起越来越多的关注。在此,我们对本院收治的并发 AIG 的胃癌患者进行了临床病理学检查:方法:2008-2022 年,我院对 50 例 AIG 并发的 86 个早期胃癌病灶进行了内镜黏膜下剥离术(ESD)治疗。将这些患者的临床病理特征与同期接受ESD治疗的2278名患者的2978个早期胃癌病灶(不包括术后残胃中的病灶)组成的对照组进行比较:AIG组的平均年龄明显高于对照组(74.7岁 vs 70.9岁;p<0.01)。在两组中,同步/不同步病变的发生率分别为 38.0% 和 20.4% (p<0.01),纵向癌变位置(上/中/下三分之一 [U/M/L])的比率分别为 27/32/27 和 518/993/1467 (p<0.01),周缘癌变位置的比率分别为 27/32/27 和 518/993/1467 (p<0.01)。01),周向癌位置(小弯/大弯/前壁/后壁)比值分别为25/31/12/18和1259/587/475/657(p<0.01),主要大体类型(I/IIa/IIb/IIc)比值分别为13/38/5/30和65/881/220/1812(p<0.01)。AIG组多发性胃癌、U区癌、大弯癌和突出型胃癌的发生率明显更高:结论:并发 AIG 的胃癌中,多发性胃癌的发生率明显更高(约 40%),与对照组相比,U 区癌、大弯癌和突出型胃癌的比例明显更高。
{"title":"Clinicopathological Features of Early Gastric Cancer Complicated by Autoimmune Gastritis.","authors":"Kosuke Nomura, Daisuke Kikuchi, Yusuke Kawai, Yorinari Ochiai, Takayuki Okamura, Yugo Suzuki, Junnosuke Hayasaka, Yutaka Mitsunaga, Hiroyuki Odagiri, Satoshi Yamashita, Akira Matsui, Shu Hoteya","doi":"10.1159/000539639","DOIUrl":"10.1159/000539639","url":null,"abstract":"<p><strong>Introduction: </strong>In the post-Helicobacter pylori era, autoimmune gastritis (AIG) is attracting increasing attention as an origin of gastric cancer. Here, we performed clinicopathological examination of gastric cancer complicating AIG treated in our hospital.</p><p><strong>Methods: </strong>Eighty-six early gastric cancer lesions complicating AIG in 50 patients were treated by endoscopic submucosal dissection (ESD) at our hospital in 2008-2022. Their clinicopathological characteristics were compared with those of a control group comprising 2,978 early gastric cancer lesions (excluding lesions in the remnant stomach after surgery) in 2,278 patients treated by ESD during the same period.</p><p><strong>Results: </strong>Mean age was significantly higher in the AIG group than in the control group (74.7 years vs. 70.9 years; p &lt; 0.01). In the respective groups, the occurrence rate of synchronous/metachronous lesions was 38.0% and 20.4% (p &lt; 0.01), the ratio of longitudinal cancer locations (upper/middle/lower third [U/M/L]) was 27/32/27 and 518/993/1,467 (p &lt; 0.01), the ratio of circumferential cancer locations (lesser curvature/greater curvature/anterior wall/posterior wall) was 25/31/12/18 and 1,259/587/475/657 (p &lt; 0.01), the ratio of major macroscopic types (I/IIa/IIb/IIc) was 13/38/5/30 and 65/881/220/1,812 (p &lt; 0.01). The rates of multiple gastric cancer and cancers in the U region, at the greater curvature, and of protruding types were significantly higher in the AIG group.</p><p><strong>Conclusion: </strong>The occurrence rate of multiple gastric cancer was significantly higher in gastric cancer complicating AIG (approximately 40%), and compared with the control group, the proportions of cancers at the U region, at the greater curvature, and of protruding types were significantly higher.</p>","PeriodicalId":11294,"journal":{"name":"Digestive Diseases","volume":" ","pages":"407-413"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457977/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141247602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy. IBD:从传统免疫抑制到生物疗法。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2023-12-14 DOI: 10.1159/000535647
Aleksandra Sokic-Milutinovic, Tomica Milosavljevic

Background: Inflammatory bowel diseases (IBDs) are chronic, recurrent inflammatory diseases with partly understood etiology and pathogenesis. The course of IBD, both ulcerative colitis and Crohn's disease, is characterized by periods of relapse and remission with the possible occurrence of extraintestinal manifestations.

Summary: During the last decades, therapeutic goals in IBD evolved toward endoscopic remission and mucosal healing creating the need for early administration of disease-modifying agents (DMAs). DMAs include conventional immunosuppressants (thiopurines, methotrexate), biologic drugs (anti-TNF, anti-integrin, and anti-IL-12/23 monoclonal antibodies), and small molecules (JAK inhibitors, S1P receptor modulators). Patients with aggressive course of disease and risk factors for poor prognosis should be treated with biologic therapy early, while conventional immunomodulators should be used in those with milder course of disease in the absence of risk factors.

Key messages: Challenges in the treatment of IBD patients include the choice of effective yet safe drug and prevention or overcoming loss of response.

背景 炎症性肠病(IBD)是一种慢性复发性炎症性疾病,其病因和发病机制尚不十分清楚。溃疡性结肠炎(UC)和克罗恩病(CD)的病程以复发和缓解期为特征,并可能出现肠外表现。摘要 在过去几十年中,IBD 的治疗目标逐渐转向内镜下缓解和粘膜愈合,因此需要尽早使用疾病改变药物(DMA)。DMA 包括传统免疫抑制剂(硫嘌呤、甲氨蝶呤)、生物药物(抗肿瘤坏死因子、抗整合素和抗 IL12/23 单克隆抗体)和小分子药物(JAK 抑制剂、S1P 受体调节剂)。对于病程凶险、有预后不良风险因素的患者,应及早采用生物疗法进行治疗。同时,对于病程较轻且无危险因素的患者,应使用常规免疫调节剂。要点 IBD 患者治疗面临的挑战包括选择有效而安全的药物,以及预防或克服反应消失。
{"title":"Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy.","authors":"Aleksandra Sokic-Milutinovic, Tomica Milosavljevic","doi":"10.1159/000535647","DOIUrl":"10.1159/000535647","url":null,"abstract":"<p><strong>Background: </strong>Inflammatory bowel diseases (IBDs) are chronic, recurrent inflammatory diseases with partly understood etiology and pathogenesis. The course of IBD, both ulcerative colitis and Crohn's disease, is characterized by periods of relapse and remission with the possible occurrence of extraintestinal manifestations.</p><p><strong>Summary: </strong>During the last decades, therapeutic goals in IBD evolved toward endoscopic remission and mucosal healing creating the need for early administration of disease-modifying agents (DMAs). DMAs include conventional immunosuppressants (thiopurines, methotrexate), biologic drugs (anti-TNF, anti-integrin, and anti-IL-12/23 monoclonal antibodies), and small molecules (JAK inhibitors, S1P receptor modulators). Patients with aggressive course of disease and risk factors for poor prognosis should be treated with biologic therapy early, while conventional immunomodulators should be used in those with milder course of disease in the absence of risk factors.</p><p><strong>Key messages: </strong>Challenges in the treatment of IBD patients include the choice of effective yet safe drug and prevention or overcoming loss of response.</p>","PeriodicalId":11294,"journal":{"name":"Digestive Diseases","volume":" ","pages":"325-335"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138801084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Forty Years of Helicobacter pylori: The African Perspective. 幽门螺杆菌四十年:非洲视角》。
IF 2.3 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2023-12-21 DOI: 10.1159/000535263
Hyasinta Jaka, Stella Ifeanyi Smith

Background: Helicobacter pylori colonises 50% of the world population and is a causative agent of gastritis, peptic ulcer disease, mucosa associate lymphoid tissue lymphoma and gastric cancer.

Summary: In Africa, the prevalence rate has been found to be the highest in comparison to other parts of the world. Despite its high prevalence there are low rates of gastric cancer recorded in Africa. This African perspective gives an insight into the history of H. pylori in Africa and also examines the issue of the so-called "African Enigma," it's diagnosis and treatment and where we are now.

Key messages: Our vision is to have an African community that is free from H. pylori infections and complications. To this end, the African Helicobacter and Microbiota Study Group was initiated in 2021 and launched on the June 27, 2022 in Lagos, Nigeria (https://ahmsg-africa.org/). The African perspective includes the need for more detailed information on actual community and hospital prevalence, resistance data, and standardizing processes and algorithms to enable comparative diagnosis and therapy of H. pylori infections using a multi-pronged approach with international support.

幽门螺杆菌是一种革兰氏阴性细菌,在全世界50%的胃中都有定植。与世界其他地区相比,非洲的发病率最高。尽管发病率很高,但非洲的胃癌发病率却很低。这篇非洲视角的文章深入探讨了幽门螺杆菌在非洲的历史,并探讨了所谓的 "非洲之谜 "等问题。
{"title":"Forty Years of Helicobacter pylori: The African Perspective.","authors":"Hyasinta Jaka, Stella Ifeanyi Smith","doi":"10.1159/000535263","DOIUrl":"10.1159/000535263","url":null,"abstract":"<p><strong>Background: </strong>Helicobacter pylori colonises 50% of the world population and is a causative agent of gastritis, peptic ulcer disease, mucosa associate lymphoid tissue lymphoma and gastric cancer.</p><p><strong>Summary: </strong>In Africa, the prevalence rate has been found to be the highest in comparison to other parts of the world. Despite its high prevalence there are low rates of gastric cancer recorded in Africa. This African perspective gives an insight into the history of H. pylori in Africa and also examines the issue of the so-called \"African Enigma,\" it's diagnosis and treatment and where we are now.</p><p><strong>Key messages: </strong>Our vision is to have an African community that is free from H. pylori infections and complications. To this end, the African Helicobacter and Microbiota Study Group was initiated in 2021 and launched on the June 27, 2022 in Lagos, Nigeria (<ext-link ext-link-type=\"uri\" xlink:href=\"https://ahmsg-africa.org/\" xmlns:xlink=\"http://www.w3.org/1999/xlink\">https://ahmsg-africa.org/</ext-link>). The African perspective includes the need for more detailed information on actual community and hospital prevalence, resistance data, and standardizing processes and algorithms to enable comparative diagnosis and therapy of H. pylori infections using a multi-pronged approach with international support.</p>","PeriodicalId":11294,"journal":{"name":"Digestive Diseases","volume":" ","pages":"161-165"},"PeriodicalIF":2.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138828745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis Value of the Blood Urea Nitrogen-to-Creatinine Ratio in Determining the Need for Intervention of Acute Upper Gastrointestinal Bleeding. 血尿素氮与肌酐比值对判断急性上消化道出血是否需要干预的诊断价值。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-03-26 DOI: 10.1159/000538366
Hong Liu, Yan Li, Chunliang Liu, Zheng Liu, Kailin Chen

Introduction: The blood urea nitrogen (BUN)-to-creatinine (Cr) ratio (BUN/Cr ratio) may be used to evaluate the need for intervention of acute upper gastrointestinal bleeding (AUGIB). This study aimed to explore the predictive value of the BUN/Cr ratio in the need for intervention of AUGIB.

Methods: This retrospective observational study included patients with AUGIB in the hospital's emergency department between August 2019 and May 2023. The patients were grouped according to whether they underwent an intervention for AUGIB. Patients treated between August 2019 and May 2022 were selected as the training set and the others as the validation set.

Results: A total of 466 patients (328 males, 138 females) with AUGIB were enrolled in the intervention group (n = 167) and the no-intervention group (n = 299). In the training set, multivariable logistic regression showed that the BUN/Cr ratio (odds ratio [OR]: 1.013, 95% confidence interval [CI]: 1.003-1.023, p = 0.009), hemoglobin (OR: 0.989, 95% CI: 0.981-0.997, p = 0.010), and a previous history of esophageal variceal bleeding (OR: 6.898, 95% CI: 3.989-11.929, p < 0.001) were independently associated with intervention for AUGIB. The area under receiver operating characteristic curve of BUN/Cr ratio and the prediction model based on logistic regression to predict the need for intervention of AUGIB were 0.604 (95% CI: 0.544-0.664) and 0.759 (95% CI: 0.706-0.812) in the training set and 0.634 (95% CI: 0.529, 0.740) and 0.708 (95% CI: 0.609, 0.806) in the validation set, respectively.

Conclusion: The BUN/Cr ratio was associated with the need for AUGIB intervention. Combining it with other parameters might improve its diagnostic value to predict the need for intervention of AUGIB.

简介:血尿素氮(BUN)与肌酐(Cr)比值(BUN/Cr 比值)可用于评估急性上消化道出血(AUGIB)的干预需求。本研究旨在探讨 BUN/Cr 比值对 AUGIB 干预需求的预测价值:这项回顾性观察研究纳入了2019年8月至2023年5月期间医院急诊科的AUGIB患者。根据患者是否接受 AUGIB 干预治疗进行分组。选取2019年8月至2022年5月期间接受治疗的患者作为训练集,其他患者作为验证集:共有466名AUGIB患者(男性328人,女性138人)被纳入干预组(167人)和非干预组(299人)。在训练集中,多变量逻辑回归显示,BUN/Cr 比值(OR:1.013,95%CI:1.003-1.023,P=0.009)、血红蛋白(OR:0.989,95%CI:0.981-0.997,P=0.010)和既往食管静脉曲张出血史(OR:6.898,95%CI:3.989-11.929,PConclusion:BUN/Cr比值与AUGIB干预的必要性有关。将其与其他参数相结合可能会提高其诊断价值,从而预测是否需要对 AUGIB 进行干预。
{"title":"Diagnosis Value of the Blood Urea Nitrogen-to-Creatinine Ratio in Determining the Need for Intervention of Acute Upper Gastrointestinal Bleeding.","authors":"Hong Liu, Yan Li, Chunliang Liu, Zheng Liu, Kailin Chen","doi":"10.1159/000538366","DOIUrl":"10.1159/000538366","url":null,"abstract":"<p><strong>Introduction: </strong>The blood urea nitrogen (BUN)-to-creatinine (Cr) ratio (BUN/Cr ratio) may be used to evaluate the need for intervention of acute upper gastrointestinal bleeding (AUGIB). This study aimed to explore the predictive value of the BUN/Cr ratio in the need for intervention of AUGIB.</p><p><strong>Methods: </strong>This retrospective observational study included patients with AUGIB in the hospital's emergency department between August 2019 and May 2023. The patients were grouped according to whether they underwent an intervention for AUGIB. Patients treated between August 2019 and May 2022 were selected as the training set and the others as the validation set.</p><p><strong>Results: </strong>A total of 466 patients (328 males, 138 females) with AUGIB were enrolled in the intervention group (n = 167) and the no-intervention group (n = 299). In the training set, multivariable logistic regression showed that the BUN/Cr ratio (odds ratio [OR]: 1.013, 95% confidence interval [CI]: 1.003-1.023, p = 0.009), hemoglobin (OR: 0.989, 95% CI: 0.981-0.997, p = 0.010), and a previous history of esophageal variceal bleeding (OR: 6.898, 95% CI: 3.989-11.929, p &lt; 0.001) were independently associated with intervention for AUGIB. The area under receiver operating characteristic curve of BUN/Cr ratio and the prediction model based on logistic regression to predict the need for intervention of AUGIB were 0.604 (95% CI: 0.544-0.664) and 0.759 (95% CI: 0.706-0.812) in the training set and 0.634 (95% CI: 0.529, 0.740) and 0.708 (95% CI: 0.609, 0.806) in the validation set, respectively.</p><p><strong>Conclusion: </strong>The BUN/Cr ratio was associated with the need for AUGIB intervention. Combining it with other parameters might improve its diagnostic value to predict the need for intervention of AUGIB.</p>","PeriodicalId":11294,"journal":{"name":"Digestive Diseases","volume":" ","pages":"285-291"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140293099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adherence to the Mediterranean Diet Is Associated with Decreased Fecal Calprotectin Levels in Children with Crohn's Disease in Clinical Remission under Biological Therapy. 坚持地中海饮食与生物治疗下临床缓解期克罗恩病儿童粪便钙保护蛋白水平降低有关。
IF 2.3 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2023-12-01 DOI: 10.1159/000535540
Rotem Sigall Boneh, Amit Assa, Raffi Lev-Tzion, Manar Matar, Dror Shouval, Chen Shubeli, Tsachi Tsadok Perets, Gabriel Chodick, Raanan Shamir

Introduction: Adherence to the Mediterranean diet (MD) was shown to be associated with decreased disease activity in adult patients with Crohn's disease (CD). Nevertheless, data on its association with fecal calprotectin (FC), particularly in children, remain limited. This study aimed to assess the association between adherence to the MD and FC as an indicator of mucosal healing in patients who are predominantly in remission while undergoing biological therapy.

Methods: This was a cross-sectional study among children with CD. Adherence to MD was evaluated using both the KIDMED questionnaire and a food frequency questionnaire (FFQ). Israeli Mediterranean Diet Adherence Screener (I-MEDAS) score was calculated, and FC samples were obtained.

Results: Of 103 eligible patients, 99 were included (mean age 14.3 ± 2.6 years; 38.4% females); 88% were in clinical remission, and 30% presented with elevated FC. The mean KIDMED score was higher among patients who had FC <200 μg/g compared to patients with FC >200 μg/g (5.48 ± 2.58 vs. 4.37 ± 2.47, respectively; p = 0.04). A moderate correlation between the KIDMED score and the I-MEDAS score was observed (r = 0.46; p = 0.001). In a multivariate regression analysis, adherence to MD was associated with decreased calprotectin levels, OR 0.75 [95% CI: 0.6-0.95], p = 0.019. Vegetable consumption was found to be inversely associated with elevated FC (0.9 portion/day [0.3-2.9] in FC >200 μg/g vs. 2.2 portions/day [0.87-3.82] in FC <200 μg/g; p = 0.049).

Conclusions: In children with CD who are mostly in clinical remission under biological therapy, high adherence to MD is associated with decreased FC levels. Encouraging vegetable consumption, especially during remission, may benefit these patients.

背景和目的:坚持地中海饮食(MD)被证明与克罗恩病(CD)成年患者疾病活动性降低相关。然而,关于其与粪便钙保护蛋白(FC)相关性的数据,特别是在儿童中,仍然有限。本研究旨在评估在接受生物治疗时主要处于缓解期的患者中,坚持MD和FC作为粘膜愈合(MH)指标之间的关系。方法:这是一项针对乳糜泻儿童的横断面研究。使用KIDMED问卷和食物频率问卷(FFQ)来评估MD的依从性。计算以色列地中海饮食依从性筛查(I-MEDAS)评分,并获得FC样本。结果:103例符合条件的患者中,99例纳入(平均年龄14.3±2.6岁;38.4%的女性);88%的患者临床缓解,30%的患者FC升高。FC200µg/g患者的平均KIDMED评分较高(分别为5.48±2.58比4.37±2.47);p = 0.04)。KIDMED评分与I-MEDAS评分之间存在中度相关性(r=0.46;p = 0.001)。在多变量回归分析中,坚持服用MD与钙保护蛋白水平降低相关,OR为0.75[95%CI: 0.6-0.95], p=0.019。蔬菜摄入量与FC水平升高呈负相关(FC>200 μ g/g组为0.9份/天[0.3-2.9],FC组为2.2份/天[0.87-3.82])。结论:在大多数经生物治疗临床缓解的CD患儿中,高依从MD与FC水平降低相关。鼓励蔬菜消费,特别是在缓解期,可能对这些患者有益。
{"title":"Adherence to the Mediterranean Diet Is Associated with Decreased Fecal Calprotectin Levels in Children with Crohn's Disease in Clinical Remission under Biological Therapy.","authors":"Rotem Sigall Boneh, Amit Assa, Raffi Lev-Tzion, Manar Matar, Dror Shouval, Chen Shubeli, Tsachi Tsadok Perets, Gabriel Chodick, Raanan Shamir","doi":"10.1159/000535540","DOIUrl":"10.1159/000535540","url":null,"abstract":"<p><strong>Introduction: </strong>Adherence to the Mediterranean diet (MD) was shown to be associated with decreased disease activity in adult patients with Crohn's disease (CD). Nevertheless, data on its association with fecal calprotectin (FC), particularly in children, remain limited. This study aimed to assess the association between adherence to the MD and FC as an indicator of mucosal healing in patients who are predominantly in remission while undergoing biological therapy.</p><p><strong>Methods: </strong>This was a cross-sectional study among children with CD. Adherence to MD was evaluated using both the KIDMED questionnaire and a food frequency questionnaire (FFQ). Israeli Mediterranean Diet Adherence Screener (I-MEDAS) score was calculated, and FC samples were obtained.</p><p><strong>Results: </strong>Of 103 eligible patients, 99 were included (mean age 14.3 ± 2.6 years; 38.4% females); 88% were in clinical remission, and 30% presented with elevated FC. The mean KIDMED score was higher among patients who had FC &lt;200 μg/g compared to patients with FC &gt;200 μg/g (5.48 ± 2.58 vs. 4.37 ± 2.47, respectively; p = 0.04). A moderate correlation between the KIDMED score and the I-MEDAS score was observed (r = 0.46; p = 0.001). In a multivariate regression analysis, adherence to MD was associated with decreased calprotectin levels, OR 0.75 [95% CI: 0.6-0.95], p = 0.019. Vegetable consumption was found to be inversely associated with elevated FC (0.9 portion/day [0.3-2.9] in FC &gt;200 μg/g vs. 2.2 portions/day [0.87-3.82] in FC &lt;200 μg/g; p = 0.049).</p><p><strong>Conclusions: </strong>In children with CD who are mostly in clinical remission under biological therapy, high adherence to MD is associated with decreased FC levels. Encouraging vegetable consumption, especially during remission, may benefit these patients.</p>","PeriodicalId":11294,"journal":{"name":"Digestive Diseases","volume":" ","pages":"199-210"},"PeriodicalIF":2.3,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10997263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138476935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Cholecystectomy Necessary after Choledocholithiasis Treatment for the Elderly or Patients with Many Comorbidities? 老年人或合并症较多的患者在胆总管结石治疗后是否有必要进行胆囊切除术?
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-08-05 DOI: 10.1159/000540661
Masahiro Shiihara, Yasuhiro Sudo, Norimasa Matsushita, Takeshi Kubota, Yasuhiro Hibi, Harushi Osugi, Tatsuo Inoue

Introduction: We evaluated the prognosis after endoscopic treatment for choledocholithiasis, particularly in patients with borderline tolerance to surgery. Stone removal and cholecystectomy are generally recommended for patients with choledocholithiasis combined with gallstones to prevent recurrent biliary events. However, the prognosis after choledocholithiasis treatment in patients with borderline tolerance to surgery, such as the elderly or those with many comorbidities, remains controversial.

Methods: We retrospectively analyzed data from patients with choledocholithiasis treated at our facility between January 2012 and December 2021. Patients who underwent endoscopic sphincterotomy were dichotomized into the cholecystectomy (CHOLE) and conservation (CONS) groups depending on whether cholecystectomy was performed, and their prognoses were subsequently compared. Furthermore, we performed a logistic regression analysis of the factors contributing to recurrent biliary events in patients with high age-adjusted Charlson Comorbidity Index (aCCI) scores.

Results: Of 169 participants, 110 had gallstones and were divided into the CHOLE (n = 56) and CONS (n = 54) groups. The CONS group was significantly ordered, had more comorbidities, and higher aCCI scores, whereas the CHOLE group had fewer recurrent biliary events, although not significant (p = 0.122). No difference was observed in the recurrent incidence of grade ≥2 biliary infections and mortality related to biliary events between the groups. In patients with aCCI scores ≥5, conservation without cholecystectomy was not an independent risk factor for recurrent biliary events.

Conclusion: Cholecystectomy after choledocholithiasis treatment prevents recurrent biliary events, but conservation without cholecystectomy is a feasible option for patients with high aCCI scores.

简介我们对胆总管结石内镜治疗后的预后进行了评估,尤其是对手术耐受性较差的患者。对于胆总管结石合并胆结石的患者,通常建议进行结石清除术和胆囊切除术,以防止胆道疾病复发。然而,对于手术耐受性不佳的患者,如老年人或合并症较多的患者,其胆总管结石治疗后的预后仍存在争议:我们回顾性分析了2012年1月至2021年12月期间在我院接受治疗的胆总管结石患者的数据。根据是否进行胆囊切除术,将接受内镜下括约肌切开术的患者分为胆囊切除术组(CHOLE)和保留胆囊组(CONS),并对他们的预后进行比较。此外,我们还对年龄调整后查尔森疾病指数(aCCI)评分较高的患者中导致胆道事件复发的因素进行了逻辑回归分析:在169名参与者中,110人患有胆结石,被分为CHOLE组(n=56)和CONS组(n=54)。CONS组患者明显有序,合并症较多,aCCI评分较高,而CHOLE组复发性胆道事件较少,但不明显(P= 0.122)。在胆道感染≥2级的复发率和胆道事件相关死亡率方面,两组间未观察到差异。在aCCI评分≥5分的患者中,不进行胆囊切除术而保留胆囊并不是胆道事件复发的独立风险因素:结论:胆总管结石治疗后进行胆囊切除术可预防复发性胆道事件,但对于 aCCI 评分较高的患者,不进行胆囊切除术而保留胆囊是一种可行的选择。
{"title":"Is Cholecystectomy Necessary after Choledocholithiasis Treatment for the Elderly or Patients with Many Comorbidities?","authors":"Masahiro Shiihara, Yasuhiro Sudo, Norimasa Matsushita, Takeshi Kubota, Yasuhiro Hibi, Harushi Osugi, Tatsuo Inoue","doi":"10.1159/000540661","DOIUrl":"10.1159/000540661","url":null,"abstract":"<p><strong>Introduction: </strong>We evaluated the prognosis after endoscopic treatment for choledocholithiasis, particularly in patients with borderline tolerance to surgery. Stone removal and cholecystectomy are generally recommended for patients with choledocholithiasis combined with gallstones to prevent recurrent biliary events. However, the prognosis after choledocholithiasis treatment in patients with borderline tolerance to surgery, such as the elderly or those with many comorbidities, remains controversial.</p><p><strong>Methods: </strong>We retrospectively analyzed data from patients with choledocholithiasis treated at our facility between January 2012 and December 2021. Patients who underwent endoscopic sphincterotomy were dichotomized into the cholecystectomy (CHOLE) and conservation (CONS) groups depending on whether cholecystectomy was performed, and their prognoses were subsequently compared. Furthermore, we performed a logistic regression analysis of the factors contributing to recurrent biliary events in patients with high age-adjusted Charlson Comorbidity Index (aCCI) scores.</p><p><strong>Results: </strong>Of 169 participants, 110 had gallstones and were divided into the CHOLE (n = 56) and CONS (n = 54) groups. The CONS group was significantly ordered, had more comorbidities, and higher aCCI scores, whereas the CHOLE group had fewer recurrent biliary events, although not significant (p = 0.122). No difference was observed in the recurrent incidence of grade ≥2 biliary infections and mortality related to biliary events between the groups. In patients with aCCI scores ≥5, conservation without cholecystectomy was not an independent risk factor for recurrent biliary events.</p><p><strong>Conclusion: </strong>Cholecystectomy after choledocholithiasis treatment prevents recurrent biliary events, but conservation without cholecystectomy is a feasible option for patients with high aCCI scores.</p>","PeriodicalId":11294,"journal":{"name":"Digestive Diseases","volume":" ","pages":"576-582"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Helminth Infections in Patients with Celiac Disease. 乳糜泻患者中蠕虫感染的流行率。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-01-01 Epub Date: 2024-08-22 DOI: 10.1159/000539581
Eli Magen, Eugene Merzon, Michal Vinker Shuster, Ilan Green, Israel Magen, Avivit Golan-Cohen, Ariel Israel

Introduction: The aim of this study was to investigate the association between helminth infections and celiac disease (CeD), examining various demographic and clinical factors in CeD cases compared to controls.

Methods: We conducted a retrospective case-control study utilizing Leumit Health Care Services' electronic health records. The study encompassed individuals with CeD and a matched control group. We analyzed demographic and clinical characteristics, examining their association with helminth infections.

Results: We observed CeD cases and controls had similar mean ages (17.8 years vs. 18.0 years, p = 0.565) and gender distributions (64.0% females in both groups, p = 0.999). There were no significant differences in socioeconomic status and ethnic distribution between the two groups. Most of the helminthiases in the CeD group were due to intestinal helminthiases, and most of the intestinal helminthiases were nematode (roundworm) infections. Enterobiasis (the pinworm Enterobius vermicularis) is involved in most cases (odds ratio 1.32, 95% confidence interval 1.20-1.45, p < 0.001). While the prevalence of ascariasis and anisakiasis was also higher in the CeD group, these differences were not statistically significant (p = 0.115 and p = 0.174, respectively). No significant differences were found in the prevalence of other specific helminth infections, such as echinococcosis, cestode infections, and strongyloidiasis.

Conclusions: This study reveals an unexpected association between CeD and helminth infections, challenging prevailing hypotheses, particularly within the context of the hygiene hypothesis. These findings warrant further investigation to elucidate the mechanisms underlying this intriguing relationship.

简介:目的:研究蠕虫感染与乳糜泻(CeD)之间的关系:目的:研究蠕虫感染与乳糜泻(Celiac disease,CeD)之间的关系,并将乳糜泻病例与对照病例的各种人口统计学和临床因素进行比较:我们利用 Leumit 医疗保健服务机构的电子健康记录开展了一项回顾性病例对照研究。研究对象包括 CeD 患者和匹配的对照组。我们分析了人口统计学和临床特征,研究了这些特征与蠕虫感染的关系:我们发现,脊髓灰质炎病例和对照组的平均年龄(17.8 岁 vs. 18.0 岁,p = 0.565)和性别分布(两组均为 64.0% 的女性,p = 0.999)相似。两组在社会经济地位和种族分布方面没有明显差异。在 CeD 组中,大多数蠕虫病都是由肠道蠕虫病引起的,而大多数肠道蠕虫病都是线虫(蛔虫)感染。大多数病例涉及肠虫病(蛲虫Enterobius vermicularis)(几率比1.32,95%置信区间1.20至1.45,p <0.001)。虽然蛔虫病和肛吸虫病的发病率在 CeD 组中也较高,但这些差异在统计学上并不显著(p = 0.115 和 p = 0.174)。其他特定蠕虫感染,如棘球蚴病、绦虫感染和强直性脊柱炎的发病率没有发现明显差异:这项研究揭示了 CeD 与蠕虫感染之间意想不到的联系,对现有假设提出了挑战,特别是在卫生假设的背景下。这些发现值得进一步研究,以阐明这种有趣关系的内在机制。
{"title":"Prevalence of Helminth Infections in Patients with Celiac Disease.","authors":"Eli Magen, Eugene Merzon, Michal Vinker Shuster, Ilan Green, Israel Magen, Avivit Golan-Cohen, Ariel Israel","doi":"10.1159/000539581","DOIUrl":"10.1159/000539581","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study was to investigate the association between helminth infections and celiac disease (CeD), examining various demographic and clinical factors in CeD cases compared to controls.</p><p><strong>Methods: </strong>We conducted a retrospective case-control study utilizing Leumit Health Care Services' electronic health records. The study encompassed individuals with CeD and a matched control group. We analyzed demographic and clinical characteristics, examining their association with helminth infections.</p><p><strong>Results: </strong>We observed CeD cases and controls had similar mean ages (17.8 years vs. 18.0 years, p = 0.565) and gender distributions (64.0% females in both groups, p = 0.999). There were no significant differences in socioeconomic status and ethnic distribution between the two groups. Most of the helminthiases in the CeD group were due to intestinal helminthiases, and most of the intestinal helminthiases were nematode (roundworm) infections. Enterobiasis (the pinworm Enterobius vermicularis) is involved in most cases (odds ratio 1.32, 95% confidence interval 1.20-1.45, p < 0.001). While the prevalence of ascariasis and anisakiasis was also higher in the CeD group, these differences were not statistically significant (p = 0.115 and p = 0.174, respectively). No significant differences were found in the prevalence of other specific helminth infections, such as echinococcosis, cestode infections, and strongyloidiasis.</p><p><strong>Conclusions: </strong>This study reveals an unexpected association between CeD and helminth infections, challenging prevailing hypotheses, particularly within the context of the hygiene hypothesis. These findings warrant further investigation to elucidate the mechanisms underlying this intriguing relationship.</p>","PeriodicalId":11294,"journal":{"name":"Digestive Diseases","volume":" ","pages":"593-599"},"PeriodicalIF":2.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Digestive Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1